Notably, the frequent co-occurrence of atherosclerosis in SLE patients stems from proinflammatory M1 macrophage activity, evidenced by elevated circulating levels of TNF-α, IFN-γ, IL-6 and IL-12—establishing a direct connection between immunosenescence and cardiovascular risk (69). Here, IL6 is linked to systemic lupus erythematosus.